Brief: Ose Immunotherapeutics Announces Peer-Reviewed Publication On Novel Myeloid Immune Checkpoint Clec-1

Ose Immunotherapeutics SA

02/04/2024 06:45

April 2 (Reuters) - OSE Immunotherapeutics SA  OSE.PA :
    * OSE IMMUNOTHERAPEUTICS ANNOUNCES PEER-REVIEWED PUBLICATION
ON
NOVEL MYELOID IMMUNE CHECKPOINT CLEC-1 IN JOURNAL OF IMMUNOLOGY
    * PUBLICATION CONFIRMED AND REINFORCED POTENTIAL OF CLEC-1
AS
NOVEL MYELOID IMMUNE CHECKPOINT REGULATING ACUTE IMMUNE
RESPONSES
    * ARTICLE CONCLUDES THAT CLEC-1 ACTS AS IMMUNE CHECKPOINT
FOR
CONTROL OF ACUTE IMMUNE RESPONSE AND RESTRAINS MYELOID CELL
INFILTRATION AND ASSOCIATED INFLAMMATION

Source text for WorkSpace:  urn:newsml:reuters.com:*:nGNE4SR3xj
Further company coverage:  OSE.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))